Xpert MTB/RIF Ultra assay for tuberculosis disease and rifampicin resistance in children
InfectologiaSobre o estudo
- Desenho
- Metanálise
- Nível de evidência
- 1 · Evidência consolidada
- Revista
- The Cochrane database of systematic reviews
- Publicado em
- 23 out 2025
- Citações
- 5
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Xpert MTB/RIF Ultra assay for tuberculosis disease and rifampicin resistance in children
Alexander W Kay, Maia Madison, Katie Scandrett, Tara Ness, Pauline Amuge, Leeberk Raja Inbaraj, Mukesh Kumar Sathya Narayanan, Lucia González Fernández, Michael Eisenhut, Nazir Ismail et al.
Descritores MeSH
- Drug Resistance, Bacterial
- Antibiotics, Antitubercular
- Mycobacterium tuberculosis
- Rifampin
- Tuberculosis
- Infant
- Infant, Newborn
- Tuberculosis, Pulmonary
- Randomized Controlled Trials as Topic
- Sensitivity and Specificity
Veja também
Estudos relacionados
- Low-complexity automated nucleic acid amplification tests for extrapulmonary tuberculosis and rifampicin resistance in adults and adolescents
- Xpert MTB/RIF Ultra assay for tuberculosis disease and rifampicin resistance in children
- Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin
- Xpert MTB/RIF Ultra assay for pulmonary tuberculosis and rifampicin resistance in adults and adolescents